These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2685505)

  • 1. [The importance of the radioimmunological determination of tumor markers in the diagnosis of malignant lymphomas].
    Purizhanskiĭ II; Pavlichuk SN; Toritsina LK
    Med Radiol (Mosk); 1989 Nov; 34(11):48-51. PubMed ID: 2685505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta 2 microglobulin in serum--a "tumor marker" in malignant lymphomas?].
    Aulbert E; Steffens O
    Med Klin (Munich); 1990 Jan; 85(1):13-7. PubMed ID: 2179698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of combined detection of LDH, TPS, CEA and beta2-MG in patients with non- Hodgkin's lymphoma].
    Chen W; Luo RC; Fan WW; Ma SD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):227-8, 230. PubMed ID: 16503538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma].
    Raida L; Papajík T; Hlusí A; Faber E; Urbanová R; Heczko M; Jancíková M; Zapletalová J; Komenda S; Indrák K
    Vnitr Lek; 2002 Feb; 48(2):91-5. PubMed ID: 11949228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioimmunological determination of tumor markers in the diagnosis of recurrences of rectal cancer].
    Ozhiganov EL; Kuznetsova LF
    Med Radiol (Mosk); 1991; 36(10):17-20. PubMed ID: 1719331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
    Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
    Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcinoembryonal antigen (CEA) in malignant lymphomas].
    Kovcin V; Jelić S; Babović N
    Srp Arh Celok Lek; 1994; 122(5-6):168-70. PubMed ID: 17977419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor markers in malignant lymphoma].
    Kato H; Ogura M
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor markers in focal and diffuse liver diseases].
    Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
    Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of malignant lymphomas by imprint cytology.
    Feinberg MR; Bhaskar AG; Bourne P
    Acta Cytol; 1980; 24(1):16-25. PubMed ID: 6928330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperprolactinemia in malignant lymphomas].
    Grobe N; Rühle H; Eckelmann G
    Dtsch Med Wochenschr; 1990 Nov; 115(48):1825-7. PubMed ID: 2245764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of biologic tests in malignant hemopathies].
    Clément F
    Schweiz Med Wochenschr; 1983 Jul; 113(26):948-51. PubMed ID: 6612275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors].
    Suzuki Y; Ishii R; Otsuka R; Ogawa Y; Kikuoka M; Hirano K; Tanaka R
    No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].
    Bień E; Balcerska A; Ciesielski D
    Wiad Lek; 2004; 57(1-2):8-11. PubMed ID: 15181741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioimmunologic analysis of ferritin, carcinoembryonic antigen and prolactin for evaluating the prognosis and effectiveness of treating breast cancer].
    Skliar SIu; Chebotareva ED; Ganul VL; Korolev VI
    Med Radiol (Mosk); 1987 Oct; 32(10):32-6. PubMed ID: 3657434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant Hodgkin's and non-Hodgkin's lymphomas].
    Hiller E
    MMW Fortschr Med; 2005 Mar; 147(9):31-4. PubMed ID: 15794351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fever of unknown origin (FUO) due to Rosai-Dorfman disease with mediastinal adenopathy mimicking lymphoma: diagnostic importance of elevated serum ferritin levels and polyclonal gammopathy.
    Cunha BA; Durie N; Selbs E; Pherez F
    Heart Lung; 2009; 38(1):83-8. PubMed ID: 19150534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.